Valdyn (valdecoxib)
- Region
- 🇪🇺 EU
- Active substance
- valdecoxib
- Company
- Pharmacia Europe EEIG
- Status
- Withdrawn
- Therapeutic area
- Osteoarthritis; Arthritis, Rheumatoid; Dysmenorrhea
- EU approval
- Thu 27 Mar 2003
- Application
- EMEA/H/C/000432
- ATC
- M01AH03
- Official record
- www.ema.europa.eu
Indication
Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.Treatment of primary dysmenorrhoea.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Bextra Withdrawn · Pharmacia - Pfizer EEIG
- 🇪🇺 Valdyn (previously Kudeq) Withdrawn · Pfizer Limited
Follow Valdyn
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.